123 related articles for article (PubMed ID: 17559911)
1. VEGF- and LPA-induced telomerase in human ovarian cancer cells is Sp1-dependent.
Bermudez Y; Yang H; Saunders BO; Cheng JQ; Nicosia SV; Kruk PA
Gynecol Oncol; 2007 Sep; 106(3):526-37. PubMed ID: 17559911
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells.
Hu YL; Tee MK; Goetzl EJ; Auersperg N; Mills GB; Ferrara N; Jaffe RB
J Natl Cancer Inst; 2001 May; 93(10):762-8. PubMed ID: 11353786
[TBL] [Abstract][Full Text] [Related]
3. Pyk2/ERK 1/2 mediate Sp1- and c-Myc-dependent induction of telomerase activity by epidermal growth factor.
Bermudez Y; Yang H; Cheng JQ; Kruk PA
Growth Factors; 2008 Feb; 26(1):1-11. PubMed ID: 18365874
[TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidic acid activates telomerase in ovarian cancer cells through hypoxia-inducible factor-1alpha and the PI3K pathway.
Yang K; Zheng D; Deng X; Bai L; Xu Y; Cong YS
J Cell Biochem; 2008 Dec; 105(5):1194-201. PubMed ID: 18802925
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between human telomerase reverse transcriptase transcriptional level and telomerase activity in three ovarian cancer cell lines].
Song Y; Kong BH; Liu PS; Ma DX; Jiang S
Ai Zheng; 2003 May; 22(5):486-91. PubMed ID: 12753708
[TBL] [Abstract][Full Text] [Related]
6. Dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells.
Hu YL; Albanese C; Pestell RG; Jaffe RB
J Natl Cancer Inst; 2003 May; 95(10):733-40. PubMed ID: 12759391
[TBL] [Abstract][Full Text] [Related]
7. LPA-induced epithelial ovarian cancer (EOC) in vitro invasion and migration are mediated by VEGF receptor-2 (VEGF-R2).
So J; Wang FQ; Navari J; Schreher J; Fishman DA
Gynecol Oncol; 2005 Jun; 97(3):870-8. PubMed ID: 15919106
[TBL] [Abstract][Full Text] [Related]
8. The NF-κB pathway mediates lysophosphatidic acid (LPA)-induced VEGF signaling and cell invasion in epithelial ovarian cancer (EOC).
Dutta S; Wang FQ; Wu HS; Mukherjee TJ; Fishman DA
Gynecol Oncol; 2011 Oct; 123(1):129-37. PubMed ID: 21782227
[TBL] [Abstract][Full Text] [Related]
9. Sp-1 and c-Myc mediate lysophosphatidic acid-induced expression of vascular endothelial growth factor in ovarian cancer cells via a hypoxia-inducible factor-1-independent mechanism.
Song Y; Wu J; Oyesanya RA; Lee Z; Mukherjee A; Fang X
Clin Cancer Res; 2009 Jan; 15(2):492-501. PubMed ID: 19147754
[TBL] [Abstract][Full Text] [Related]
10. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional repression of telomerase RNA gene expression by c-Jun-NH2-kinase and Sp1/Sp3.
Bilsland AE; Stevenson K; Atkinson S; Kolch W; Keith WN
Cancer Res; 2006 Feb; 66(3):1363-70. PubMed ID: 16452190
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor-2, but not vascular endothelial growth factor, upregulates telomerase activity in human endothelial cells.
Kurz DJ; Hong Y; Trivier E; Huang HL; Decary S; Zang GH; Lüscher TF; Erusalimsky JD
Arterioscler Thromb Vasc Biol; 2003 May; 23(5):748-54. PubMed ID: 12676798
[TBL] [Abstract][Full Text] [Related]
13. Activation of hypoxia-inducible factor-1alpha is necessary for lysophosphatidic acid-induced vascular endothelial growth factor expression.
Lee J; Park SY; Lee EK; Park CG; Chung HC; Rha SY; Kim YK; Bae GU; Kim BK; Han JW; Lee HY
Clin Cancer Res; 2006 Nov; 12(21):6351-8. PubMed ID: 17085645
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells.
Symowicz J; Adley BP; Woo MM; Auersperg N; Hudson LG; Stack MS
Cancer Res; 2005 Mar; 65(6):2234-42. PubMed ID: 15781636
[TBL] [Abstract][Full Text] [Related]
15. Vitamin E suppresses telomerase activity in ovarian cancer cells.
Bermudez Y; Ahmadi S; Lowell NE; Kruk PA
Cancer Detect Prev; 2007; 31(2):119-28. PubMed ID: 17335992
[TBL] [Abstract][Full Text] [Related]
16. VEGFR-2 silencing by small interference RNA (siRNA) suppresses LPA-induced epithelial ovarian cancer (EOC) invasion.
Wang FQ; Barfield E; Dutta S; Pua T; Fishman DA
Gynecol Oncol; 2009 Dec; 115(3):414-23. PubMed ID: 19765808
[TBL] [Abstract][Full Text] [Related]
17. Ovarian cancer-derived lysophosphatidic acid stimulates secretion of VEGF and stromal cell-derived factor-1 alpha from human mesenchymal stem cells.
Jeon ES; Heo SC; Lee IH; Choi YJ; Park JH; Choi KU; Park DY; Suh DS; Yoon MS; Kim JH
Exp Mol Med; 2010 Apr; 42(4):280-93. PubMed ID: 20177148
[TBL] [Abstract][Full Text] [Related]
18. Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancer.
Tanyi JL; Hasegawa Y; Lapushin R; Morris AJ; Wolf JK; Berchuck A; Lu K; Smith DI; Kalli K; Hartmann LC; McCune K; Fishman D; Broaddus R; Cheng KW; Atkinson EN; Yamal JM; Bast RC; Felix EA; Newman RA; Mills GB
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3534-45. PubMed ID: 14506139
[TBL] [Abstract][Full Text] [Related]
19. RIF1 promotes human epithelial ovarian cancer growth and progression via activating human telomerase reverse transcriptase expression.
Liu YB; Mei Y; Long J; Zhang Y; Hu DL; Zhou HH
J Exp Clin Cancer Res; 2018 Aug; 37(1):182. PubMed ID: 30075819
[TBL] [Abstract][Full Text] [Related]
20. [In vitro treatment of ovarian cancer cells with cytosine deaminase-thymidine kinase fusion disuicide gene therapy system under the control of human telomerase reverse transcriptase gene promoter].
Kong BH; Song Y; Ma DX; Qu X; Jiang S
Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):390-5. PubMed ID: 15312323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]